Inventor
THOMAS JOSEPH TUCKER
Inventor
US
Overview
Patents· 11 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
C07KPeptides24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C12NMicroorganisms or enzymes12%
C12YEnzymes10%
C07DHeterocyclic compounds5%
C07HSugars2%
PatentTitleYear
12,577,259PCSK9 antagonist compounds202612,304,925Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides202512,209,145PCSK9 antagonist compounds202512,178,842PCSK9 antagonist compounds202412,012,468Cyclic polypeptides for PCSK9 inhibition202411,932,705Cyclic polypeptides for PCSK9 inhibition202411,530,244Cyclic polypeptides for PCSK9 inhibition202211,505,575Cyclic polypeptides for PCSK9 inhibition202211,484,565PCSK9 antagonist compounds202211,427,616PCSK9 antagonist compounds202211,306,125PCSK9 antagonists bicyclo-compounds2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to MERCK SHARP & DOHME LLC (9)· patent assignee history
2022–2024Patents assigned to RA PHARMACEUTICALS INC (4)· patent assignee history
2022Patents assigned to MERCK SHARP & DOHME (1)· patent assignee history
2022–2026Based in US· patent location history
2025Patents assigned to SIRNA THERAPEUTICS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME LLC | 9 | 2022–2026 |
| RA PHARMACEUTICALS INC | 4 | 2022–2024 |
| MERCK SHARP & DOHME | 1 | 2022 |
| SIRNA THERAPEUTICS INC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 11 | 2022–2026 |